SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3,149.81 |
Enterprise Value ($M) | 3,313.30 |
Book Value ($M) | 164.55 |
Book Value / Share | 2.60 |
Price / Book | 19.14 |
NCAV ($M) | 146.48 |
NCAV / Share | 2.32 |
Price / NCAV | 21.50 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.94 |
Return on Assets (ROA) | -1.01 |
Return on Equity (ROE) | -4.23 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.08 |
Current Ratio | 3.24 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 374.20 |
Assets | 392.27 |
Liabilities | 227.72 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 130.13 |
Operating Income | -265.50 |
Net Income | -260.60 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -113.88 |
Cash from Investing | -48.17 |
Cash from Financing | 191.24 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Primecap Management Co/ca/ | 10.69 | -8.95 | |
13G/A | Goldman Sachs Group Inc | 3.00 | -53.25 | |
13G | Perceptive Advisors Llc | 8.60 | 5.67 | |
13G/A | Ra Capital Management, L.p. | 9.95 | 14.15 | |
13D/A | New Enterprise Associates 13 Lp |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
75,226 | 457,980 | 16.43 | |
46,172 | 452,228 | 10.21 | |
71,154 | 689,325 | 10.32 | |
75,365 | 556,818 | 13.53 | |
91,071 | 352,484 | 25.84 | |
(click for more detail) |
Similar Companies | |
---|---|
RLAY – Relay Therapeutics, Inc. | RNA – Avidity Biosciences, Inc. |
RNAC – Cartesian Therapeutics, Inc. | SAGE – Sage Therapeutics, Inc. |
SCYX – SCYNEXIS, Inc. |
Financial data and stock pages provided by
Fintel.io